Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose liposomal amphotericin B vs standard-dose amphotericin B in rhino-orbital mucormycosis
IRCT20201015049030N4Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of liposomal amphotericin b and amphotericin b in mucormycosis (2 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
liposomal amphotericin bamphotericin b
03
Conditions
mucormycosis
Beyond the preview
Go deeper on IRCT20201015049030N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201015049030N4.